000			01528 a2200397 4500
005			20250515155926.0
264		0	_c20090825
008			200908s 0 0 eng d
022			_a1476-5500
024	7		_a10.1038/cgt.2009.2 _2doi
040			_aNLM _beng _cNLM
100	1		_aFisher, M B
245	0	0	_aMeasuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker. _h[electronic resource]
260			_bCancer gene therapy _cJul 2009
300			_a567-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdenoviridae _xgenetics
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCulture Media, Conditioned _xpharmacology
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xgenetics
650	0	4	_aKeratin-18 _xmetabolism
650	0	4	_aNecrosis _xchemically induced
650	0	4	_aRecombinant Proteins
650	0	4	_aUrinary Bladder Neoplasms _xtherapy
700	1		_aZhang, X-Q
700	1		_aMcConkey, D J
700	1		_aBenedict, W F
773	0		_tCancer gene therapy _gvol. 16 _gno. 7 _gp. 567-72
856	4	0	_uhttps://doi.org/10.1038/cgt.2009.2 _zAvailable from publisher's website
999			_c18641760 _d18641760